Categories: Critical Illness| Critical Illness| Critical Illness
Topics: Critical Illness| non-disclosure| Aviva
Aviva has increased its critical illness (CI) claims payment rate to 93% in the first six months of 2010.
The figure is a 2% improvement on the same period last year while it also halved the volume of claims declined through non-disclosure to 1%.
In all, the provider paid out 684 CI claims during the six months to the end of June 2010, totaling over £51m, with an average payment of £74,740.
Cancer remains the most common cause of critical illness claim, accounting for 64% of claims.
It also revealed a 98.5% payment rate for death claims, paying out a further £87 million in life insurance after death or to clients diagnosed with a terminal illness.
Richard Verdin, protection director at Aviva, is pleased with the figures.
"We're here to offer our customers peace of mind, and making a claim is the moment of truth," he says.
"We're constantly reviewing our claims process to make it as easy as possible for customers, especially at such a difficult time and so have introduced a telephone claims service, which accounts for 67% of all claims.
"This cuts the time to process the claim by a third," he adds.
| Share | |
| Comment | Aviva ups CI pay out rate |
More from cover
Email alerts
Recommended reading
Categories
Topics
Comments
Related articles
Most Read
This year we have 14 awards designed to mark out the very best products in a highly competitive and innovative market. This includes three new awards for 2011 to reflect the developments in this rapidly growing market: Best Dual/Multi-Index Product, Best Structured (Oeic) Fund and Best Structured Product Provider.
Events
Poll
|
|
Job search
Ifaonlinejobs will open the right investment career path for you. Search hundreds of vacancies on www.ifaonlinejobs.co.uk now
In Focus
Transferring clients’ assets between organisations can be a major headache – often time...
Viewpoints
At the start of one of busiest times of year it is easy to think about all the obvious things...
There are no comments submitted yet. Do you have an interesting opinion? Then be the first to post a comment